Paul Hartmann Past Earnings Performance
Past criteria checks 4/6
Paul Hartmann's earnings have been declining at an average annual rate of -17.7%, while the Medical Equipment industry saw earnings declining at 1.1% annually. Revenues have been growing at an average rate of 1.1% per year. Paul Hartmann's return on equity is 5.7%, and it has net margins of 2.5%.
Key information
-17.7%
Earnings growth rate
-17.7%
EPS growth rate
Medical Equipment Industry Growth | 4.3% |
Revenue growth rate | 1.1% |
Return on equity | 5.7% |
Net Margin | 2.5% |
Last Earnings Update | 30 Jun 2024 |
Recent past performance updates
Recent updates
Paul Hartmann's (FRA:PHH2) Problems Go Beyond Weak Profit
Mar 25Calculating The Fair Value Of Paul Hartmann AG (FRA:PHH2)
Mar 08Getting In Cheap On Paul Hartmann AG (FRA:PHH2) Is Unlikely
Jan 31Paul Hartmann (FRA:PHH2) Has A Somewhat Strained Balance Sheet
Nov 16The Returns On Capital At Paul Hartmann (FRA:PHH2) Don't Inspire Confidence
Jul 05Is Paul Hartmann (FRA:PHH2) A Risky Investment?
May 06Paul Hartmann's (FRA:PHH2) Returns On Capital Not Reflecting Well On The Business
Jan 07Here's What's Concerning About Paul Hartmann's (FRA:PHH2) Returns On Capital
Sep 03Here's Why Paul Hartmann (FRA:PHH2) Can Manage Its Debt Responsibly
Apr 02Paul Hartmann (FRA:PHH2) Shareholders Will Want The ROCE Trajectory To Continue
Mar 09Is Paul Hartmann (FRA:PHH2) Using Too Much Debt?
Nov 24There's Been No Shortage Of Growth Recently For Paul Hartmann's (FRA:PHH2) Returns On Capital
May 19We Think Paul Hartmann (FRA:PHH2) Can Manage Its Debt With Ease
Apr 12Should You Buy Paul Hartmann AG (FRA:PHH2) For Its Dividend?
Mar 25Does Paul Hartmann's (FRA:PHH2) Share Price Gain of 29% Match Its Business Performance?
Feb 24Paul Hartmann AG's (FRA:PHH2) Stock Has Seen Strong Momentum: Does That Call For Deeper Study Of Its Financial Prospects?
Feb 03We're Watching These Trends At Paul Hartmann (FRA:PHH2)
Dec 29How Does Paul Hartmann AG (FRA:PHH2) Fare As A Dividend Stock?
Dec 11If You Had Bought Paul Hartmann's (FRA:PHH2) Shares Three Years Ago You Would Be Down 16%
Nov 23Revenue & Expenses Breakdown
How Paul Hartmann makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
30 Jun 24 | 2,398 | 60 | 772 | 0 |
31 Mar 24 | 2,383 | 44 | 767 | 0 |
31 Dec 23 | 2,367 | 28 | 762 | 0 |
30 Sep 23 | 2,365 | 26 | 754 | 0 |
30 Jun 23 | 2,363 | 23 | 745 | 0 |
31 Mar 23 | 2,342 | 30 | 738 | 0 |
31 Dec 22 | 2,320 | 36 | 731 | 0 |
30 Sep 22 | 2,300 | 46 | 728 | 0 |
30 Jun 22 | 2,281 | 56 | 725 | 0 |
31 Mar 22 | 2,296 | 75 | 726 | 0 |
31 Dec 21 | 2,311 | 95 | 727 | 0 |
30 Sep 21 | 2,335 | 99 | 725 | 0 |
30 Jun 21 | 2,359 | 103 | 723 | 0 |
31 Mar 21 | 2,400 | 105 | 718 | 0 |
31 Dec 20 | 2,440 | 106 | 713 | 0 |
30 Sep 20 | 2,397 | 99 | 702 | 0 |
30 Jun 20 | 2,354 | 92 | 692 | 0 |
31 Mar 20 | 2,274 | 75 | 686 | 0 |
31 Dec 19 | 2,194 | 58 | 680 | 0 |
30 Sep 19 | 2,179 | 66 | 687 | 0 |
30 Jun 19 | 2,163 | 74 | 694 | 0 |
31 Mar 19 | 2,144 | 76 | 686 | 0 |
31 Dec 18 | 2,125 | 79 | 679 | 0 |
30 Sep 18 | 2,109 | 82 | 672 | 0 |
30 Jun 18 | 2,093 | 84 | 664 | 0 |
31 Mar 18 | 2,078 | 86 | 658 | 0 |
31 Dec 17 | 2,063 | 88 | 653 | 0 |
30 Sep 17 | 2,043 | 87 | 649 | 0 |
30 Jun 17 | 2,024 | 85 | 646 | 0 |
31 Mar 17 | 2,007 | 85 | 639 | 0 |
31 Dec 16 | 1,991 | 85 | 631 | 0 |
30 Sep 16 | 1,978 | 84 | 616 | 0 |
30 Jun 16 | 1,964 | 84 | 602 | 0 |
31 Mar 16 | 1,955 | 81 | 598 | 0 |
31 Dec 15 | 1,946 | 79 | 594 | 0 |
30 Sep 15 | 1,929 | 77 | 590 | 0 |
30 Jun 15 | 1,912 | 75 | 585 | 0 |
31 Mar 15 | 1,889 | 74 | 579 | 0 |
31 Dec 14 | 1,866 | 74 | 573 | 0 |
30 Sep 14 | 1,842 | 69 | 562 | 0 |
30 Jun 14 | 1,818 | 65 | 550 | 0 |
31 Mar 14 | 1,807 | 61 | 548 | 0 |
31 Dec 13 | 1,797 | 57 | 547 | 0 |
Quality Earnings: PHH2 has high quality earnings.
Growing Profit Margin: PHH2's current net profit margins (2.5%) are higher than last year (1%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: PHH2's earnings have declined by 17.7% per year over the past 5 years.
Accelerating Growth: PHH2's earnings growth over the past year (156.1%) exceeds its 5-year average (-17.7% per year).
Earnings vs Industry: PHH2 earnings growth over the past year (156.1%) exceeded the Medical Equipment industry 10.1%.
Return on Equity
High ROE: PHH2's Return on Equity (5.7%) is considered low.